News and Press Releases
Waltham, MA, US – June 8, 2023 – Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art cGMP manufacturing site…
June 8, 2023
Waltham, MA, US – May 24, 2023 – Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art cGMP manufacturing site…
May 24, 2023
Kiel, Germany, May 16, 2023 – tiakis Biotech AG (tiakis), in collaboration with its CDMO partner Northway Biotech, is pleased to announce the successful completion of a technology transfer and…
May 16, 2023
SYDNEY, AUSTRALIA – 06 December 2022 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease,…
December 6, 2022
SYDNEY, AUSTRALIA – 16 December 2021 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune…
December 16, 2021
WALTHAM, Mass and VILNIUS, Lithuania, and NEW ORLEANS and LONDON – June 9, 2021 – Northway Biotech, a global end-to-end biopharmaceutical contract development and manufacturing organization (CDMO), announced today that…
June 9, 2021